Back to Results
First PageMeta Content
Vemurafenib / Cancer / Metastasis / Protein kinase inhibitor / Medicine / Melanoma / BRAF


MSAC Application 1207: Consultation Decision Analytical Protocol (DAP) to guide the assessment of BRAF genetic testing in patients with melanoma for access to proposed PBS-funded GSK2118436 treatment January 2012
Add to Reading List

Document Date: 2014-11-06 23:50:11


Open Document

File Size: 751,05 KB

Share Result on Facebook

Company

Roche Diagnostics Australia Pty Ltd / GlaxoSmithKline Australia / Molecular Pathology Frome Rd SA / /

Country

Australia / /

Currency

USD / /

Event

FDA Phase / /

Facility

The laboratory / Hunter Area Pathology Service John Hunter Hospital / University of Adelaide / Royal College of Pathologists / /

IndustryTerm

nucleotide solution / technology changes / healthcare resources / decision analytical protocol / proposed biomarker-drug co-dependent technology / /

MedicalCondition

regional and distant metastases / non-resectable melanoma / resectable stage IIIA melanoma / metastasis / skin cancer / cutaneous melanoma T / infectious / IV metastatic disease / additional tumours / melanoma / IV cutaneous melanoma / cancer / disease / further disease / congenital disorders / IV melanoma / resectable stage IIIC disease / tumour / melanomas / primary melanoma / clinically detectable nodal metastases / transit metastases / cutaneous melanoma / metastases / infectious disease / distant metastases / metastatic melanoma / tumours / /

MedicalTreatment

chemotherapy / oral therapy / bypass / /

Organization

University of Adelaide / Royal College of Pathologists of Australasia / School of Population Health and Clinical Practice / Therapeutic Goods Administration / Australian government / American Joint Committee on Cancer / Department of Neuropathology Royal Prince Alfred Hospital NSW / Peter MacCallum Centre / Medicare / Hunter Area Pathology Service John Hunter Hospital / Department of Health / Medical Services Advisory Committee / /

Person

Clarification / /

Position

Commonwealth Minister / molecular scientist / scientist / technician / pathologist / medical oncologist or surgeon / supervisor / Governor / Health Minister / anatomical pathologist / pathologist / surgeon / senior scientist / suitably qualified pathologist / /

Product

dacarbazine / 27T14 / V600 / /

Technology

radiation / electrophoresis / proposed biomarker-drug co-dependent technology / Consultation Decision Analytical Protocol / decision analytical protocol / gene expression / chemotherapy / /

URL

http /

SocialTag